Mobile Trading

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE3144.3555.55 (+1.8 %)
PREV CLOSE ( ) 3088.80
OPEN PRICE ( ) 3065.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2863
TODAY'S LOW / HIGH ( )3000.00 3175.40
52 WK LOW / HIGH ( )1924.3 3515.95
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)54.7634.8336.05100.0421.14
   CEPS(Rs)58.7038.9439.7526.5021.60
   DPS(Rs)54.0032.0032.0090.0030.00
   Book NAV/Share(Rs)116.06105.47102.89157.1987.26
   Tax Rate(%)26.3827.7227.3551.1236.72
Margin Ratios
   Core EBITDA Margin(%)28.5624.0124.7321.2019.14
   EBIT Margin(%)30.5921.6125.7821.7314.64
   Pre Tax Margin(%)30.5621.5725.7221.6714.53
   PAT Margin (%)22.5015.5918.6910.599.19
   Cash Profit Margin (%)24.1217.4320.7112.4911.71
Performance Ratios
   ROA(%)25.1517.8715.7610.119.52
   ROE(%)49.4333.4327.5818.3917.42
   ROCE(%)67.6446.4938.0637.7227.74
   Asset Turnover(x)1.121.150.840.951.04
   Sales/Fixed Asset(x)6.205.845.316.033.04
   Working Capital/Sales(x)2.742.972.781.794.68
Efficiency Ratios
   Fixed Capital/Sales(x)0.160.170.190.170.33
   Receivable days22.7819.9822.3221.3718.42
   Inventory Days44.5747.5055.8254.9160.14
   Payable days174.99144.03143.05140.69119.53
Valuation Parameters
   PER(x)52.5555.8036.7316.6268.13
   PCE(x)49.0249.9033.3162.7566.69
   Price/Book(x)24.7918.4212.8710.5816.51
   Yield(%)1.881.652.425.412.08
   EV/Net Sales(x)12.639.226.547.847.94
   EV/Core EBITDA(x)35.7730.8923.5130.6732.80
   EV/EBIT(x)37.5438.9425.3832.8950.80
   EV/CE(x)24.2617.9212.225.687.72
   M Cap / Sales13.009.536.908.598.34
Growth Ratio
   Net Sales Growth(%)8.566.21-0.8012.05-9.27
   Core EBITDA Growth(%)28.3213.968.0318.19-3.74
   EBIT Growth(%)54.18-2.417.3270.7146.60
   PAT Growth(%)57.23-2.9159.5832.55208.21
   EPS Growth(%)57.23-3.39-63.97373.19284.26
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)1.791.841.882.181.49
   Quick Ratio(x)1.541.491.531.871.09
   Interest Cover(x)960.03454.77462.54391.29129.56
   Total Debt/Mcap(x)0.000.000.000.00

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.